Home › Multiple Sclerosis › Georgia
Multiple Sclerosis clinical trials in Georgia
7 studies for Multiple Sclerosis are looking for participants at sites in Georgia.
Cities in Georgia
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 102, Atlanta
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Atlanta
- TG Therapeutics Investigational Trial Site, Atlanta
- TG Therapeutics Investigational Trial Site, Savannah
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Joi Life Wellness Group LLC- Site Number : 8400192, Smyrna
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Emory University, Atlanta
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Atlanta Neuroscience Institute, Atlanta
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 8, 2026 · NCT07609719A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Joi Life Wellness Group LLC, Smyrna
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
- Emory Univeristy, Atlanta
RecruitingHealthy volunteers welcome
Ages 18 to 89 · All sexes · Updated Jul 16, 2025 · NCT06495138From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.